Sotera Health Co
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
SHC$16.27-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Income (Loss)
(in thousands, except per share amounts)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revenues: | |||
| Service | $941,822 | $905,598 | $864,828 |
| Product | 158,619 | 143,690 | 138,859 |
| Total net revenues | 1,100,441 | 1,049,288 | 1,003,687 |
| Cost of revenues: | |||
| Service | 439,543 | 418,611 | 390,860 |
| Product | 58,603 | 53,519 | 55,823 |
| Total cost of revenues | 498,146 | 472,130 | 446,683 |
| Gross profit | 602,295 | 577,158 | 557,004 |
| Operating expenses: | |||
| Selling, general and administrative expenses | 242,630 | 236,667 | 245,714 |
| Amortization of intangible assets | 62,039 | 63,799 | 62,940 |
| Total operating expenses | 304,669 | 300,466 | 308,654 |
| Operating income | 297,626 | 276,692 | 248,350 |
| Interest expense, net | 164,691 | 142,878 | 80,144 |
| Loss on refinancing of debt | 24,168 | — | — |
| Georgia EO litigation settlement | — | 35,000 | — |
| Illinois EO litigation settlement | — | — | 408,000 |
| Impairment of investment in unconsolidated affiliate | — | — | 9,613 |
| Foreign exchange loss | 199 | 159 | 145 |
| Other income, net | (5,306) | (7,372) | (6,441) |
| Income (loss) before income taxes | 113,874 | 106,027 | (243,111) |
| Provision (benefit) for income taxes | 69,476 | 54,651 | (9,541) |
| Net income (loss) | $44,398 | $51,376 | $(233,570) |
| Other comprehensive income (loss), net of tax: | |||
| Pension and post-retirement benefits (net of taxes of $2,804, $(3,420) and $7,022, respectively) | $8,462 | $(10,506) | $20,790 |
| Interest rate derivatives (net of taxes of $(1,856), $(5,467) and $7,387, respectively) | (5,396) | (15,697) | 20,939 |
| Foreign currency translation | (118,635) | 40,174 | (64,816) |
| Comprehensive income (loss) | $(71,171) | $65,347 | $(256,657) |
| Earnings (Loss) per share: | |||
| Basic | $0.16 | $0.18 | $(0.83) |
| Diluted | 0.16 | 0.18 | (0.83) |
| Weighted average number of shares outstanding: | |||
| Basic | 282,784 | 281,008 | 280,096 |
| Diluted | 284,906 | 283,222 | 280,096 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.